Diagnosis and treatment of adenomyosis

. 2021 Feb 16;193(7):E242.

doi: 10.1503/cmaj.201607.

Affiliations

¹ Department of Obstetrics and Gynaecology (Dason), University of Toronto; Department of Obstetrics and Gynaecology (Sobel, Chan), Mount Sinai Hospital, Toronto, Ont. shirin.dason@mail.utoronto.ca.
² Department of Obstetrics and Gynaecology (Dason), University of Toronto; Department of Obstetrics and Gynaecology (Sobel, Chan), Mount Sinai Hospital, Toronto, Ont.

Ebernella Shirin Dason et al. CMAJ. 2021.

. 2021 Feb 16;193(7):E242.

doi: 10.1503/cmaj.201607.

¹ Department of Obstetrics and Gynaecology (Dason), University of Toronto; Department of Obstetrics and Gynaecology (Sobel, Chan), Mount Sinai Hospital, Toronto, Ont. shirin.dason@mail.utoronto.ca.
² Department of Obstetrics and Gynaecology (Dason), University of Toronto; Department of Obstetrics and Gynaecology (Sobel, Chan), Mount Sinai Hospital, Toronto, Ont.

No abstract available

Conflict of interest statement

Competing interests: None declared.

Comprehensive transcriptional atlas of human adenomyosis deciphered by the integration of single-cell RNA-sequencing and spatial transcriptomics.
Chen T, Xu Y, Xu X, Wang J, Qiu Z, Yu Y, Jiang X, Shao W, Bai D, Wang M, Mei S, Cheng T, Wu L, Gao S, Che X. Chen T, et al. Protein Cell. 2024 Jul 1;15(7):530-546. doi: 10.1093/procel/pwae012. Protein Cell. 2024. PMID: 38486356 Free PMC article.
The role of different LNG-IUS therapies in the management of adenomyosis: a systematic review and meta-analysis.
Zhang B, Shi J, Gu Z, Wu Y, Li X, Zhang C, Yan H, Li Q, Lyu S, Dai Y, Leng J. Zhang B, et al. Reprod Biol Endocrinol. 2025 Feb 13;23(1):23. doi: 10.1186/s12958-025-01349-4. Reprod Biol Endocrinol. 2025. PMID: 39948612 Free PMC article.
Ulipristal Acetate in Adenomyosis.
Gonçalves-Henriques M, de Pinho A, Freixo M, Liz-Coelho M, Castro F, Ceschin N, Brandão P. Gonçalves-Henriques M, et al. Gynecol Minim Invasive Ther. 2022 Oct 7;11(4):198-202. doi: 10.4103/gmit.gmit_95_21. eCollection 2022 Oct-Dec. Gynecol Minim Invasive Ther. 2022. PMID: 36660320 Free PMC article. Review.
Efficacy of hysteroscopic levonorgestrel‑releasing intrauterine device fixation in the treatment of adenomyosis: A cohort study.
Xu P, Ling S, Hu E, Ma L, Liu J, Yi B. Xu P, et al. Biomed Rep. 2024 Jun 4;21(1):109. doi: 10.3892/br.2024.1797. eCollection 2024 Jul. Biomed Rep. 2024. PMID: 38868528 Free PMC article.

1. Gordts S, Grimbizis G, Campo R. Symptoms and classification of uterine adenomyosis, including the place of hysteroscopy in diagnosis. Fertil Steril 2018;109:380–8.e1. - PubMed
1. Chapron C, Vannuccini S, Santulli P, et al. . Diagnosing adenomyosis: an integrated clinical and imaging approach. Hum Reprod Update 2020;26:392–411. - PubMed
1. Vannuccini S, Luisi S, Tosti C, et al. . Role of medical therapy in the management of uterine adenomyosis. Fertil Steril 2018; 109:398–405. - PubMed
1. Yu O, Schulze-Rath R, Grafton J, et al. . Adenomyosis incidence, prevalence and treatment: United States population-based study 2006–2015. Am J Obstet Gynecol 2020;223:94..e1–10. - PubMed
1. Benetti-Pinto CL, de Mira TAA, Yela DA, et al. . Pharmacological treatment for symptomatic adenomyosis: a systematic review. Rev Bras Ginecol Obstet 2019;41:564–74. - PubMed